Career opportunities at MRC-Holland
MRC-Holland is a fast-growing biotechnology company based in the Amsterdam Baarsjes. MRC-Holland consists of a multinational team of about 70 employees. MRC-Holland is the inventor of the Multiplex Ligation-dependent Probe Amplification (MLPA) technique, a sensitive method to detect copy number changes in genes. MLPA is used in hundreds of labs and hospitals worldwide for many different applications, including mutation detection in hereditary diseases and subtyping of tumours. Because of continuous growth, we are looking for:

new products
P420-MPN mix 1
Myeloproliferative neoplasms
P475-FOXP1 - FOXP2
mental retardation
P520-MPN mix 2
Myeloproliferative neoplasms
improved products
P077-BRCA2 Confirmation
Breast cancer, hereditary
P318-Hirschsprung-2
Hirschsprung disease
P083-CDH1
Hereditary diffuse gastric cancer
P066-Marfan Syndrome-2
Marfan syndrome
P065-Marfan Syndrome-1
Marfan syndrome
P081-NF1 mix 1
Neurofibromatosis
P262-GHI
Growth Hormone Insensitivity (GHI)
Newsletter  |  Home  |  Site map  |  Terms and Conditions  |  Search  |  Copyright © 2017 MRC-Holland